FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce ...

FDA approves Alhemo®, a subcutaneous injection for hemophilia A or B with inhibitors, reducing bleeds by 86% in prophylaxis users.


Related News

FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce ...

FDA approves Alhemo®, a subcutaneous injection for hemophilia A or B with inhibitors, reducing bleeds by 86% in prophylaxis users.

© Copyright 2024. All Rights Reserved by MedPath